Progyny, Inc
Price
FilingsNewest: 10-Q, Quarterly reportAug 7 →Insiders1 insider bought $1.9M in 1 open-market buy. 6 insiders sold $1.8M, 17 of 20 sales on a 10b5-1 plan.→HoldersBlackRock 15.0%FMR 9.1%Vanguard Portfolio 6.5%→PeersClosest companies: TDOC, LFST, AMWL→
From the filings
Figures
- Revenue
- $1.31Blast 12 months
- Net income
- $78.6Mlast 12 months
- Operating cash flow
- $206.3Mlast 12 months
- Cash and equivalents
- $152.6Mat the last balance sheet
- Shares outstanding
- 77.4M shareson issue